Edition:
United Kingdom

Mabion SA (MABP.WA)

MABP.WA on Warsaw Stock Exchange

90.00PLN
16 Nov 2018
Change (% chg)

-1.30zł (-1.42%)
Prev Close
91.30zł
Open
90.90zł
Day's High
90.90zł
Day's Low
82.00zł
Volume
6,535
Avg. Vol
6,815
52-wk High
139.00zł
52-wk Low
82.00zł

Chart for

About

Mabion SA is a Poland-based company engaged in the research and development of biotechnological and biopharmaceutical medicinal products. Mabion SA was founded by four pharmaceutical companies, including Celon Pharma Ltd, Polfarmex Co, Genexo Ltd and IBSS Biomed Co, as well as two companies focused on research and development in... (more)

Overall

Beta: 0.80
Market Cap(Mil.): zł1,233.10
Shares Outstanding(Mil.): 11.80
Dividend: --
Yield (%): --

Financials

  MABP.WA Industry Sector
P/E (TTM): -- 83.63 33.59
EPS (TTM): -4.82 -- --
ROI: -64.66 -0.64 15.05
ROE: -99.15 0.08 16.62

BRIEF- Mabion Q3 Net Loss Narrows To 11.1 Mln Zlotys

* SAID ON THURSDAY Q3 NET LOSS WAS AT 11.1 MLN ZLOTYS VS LOSS OF 13.2 MLN ZLOTYS YR AGO

16 Nov 2018

BRIEF-Mabion Files Second Patent Application

* SAID ON FRIDAY IT FILED A SECOND PATENT APPLICATION FOR ITS INVENTION FROM AREA OF ​​APPLICATION OF MABIONCD20 IN TREATMENT OF PATIENTS WITH MULTIPLE SCLEROSIS 'LOW AGGREGATE ANTI CD20 LIGAND FORMULATION'

29 Oct 2018

BRIEF-Mabion Q2 Net Loss Widens To 26.8 Mln Zlotys

* REPORTED ON THURSDAY Q2 NET LOSS OF 26.8 MLN ZLOTYS VS LOSS 12.5 MLN ZLOTYS YEAR AGO

14 Sep 2018

Earnings vs. Estimates